Xunlei Announces Appointment of Two New Directors
GlobeNewswire News Room· 2024-09-23 20:00
SHENZHEN, China, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq: XNET), a leading technology company providing distributed cloud services in China, today announced that the board of directors of the Company has appointed Mr. Hui Duan and Mr. Xiaosong Li as members of the board of directors of the Company, effective today. Mr. Hui Duan had served as a director of Xunlei from April 2020 to September 2023. He currently serves as the Chief Technology Officer of Beijing Itu ...
Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology Congress
GlobeNewswire News Room· 2024-09-23 20:00
Oral and poster presentations of results from Study 501 evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) Poster presentations of post-hoc analyses from Study 403 including the prespecified patient population with MDD or bipolar depression with mixed features who also had anxious distress NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the developmen ...
Monster Digital Adds Significant Digital Production Capacity with the Adoption of 10 Additional Kornit Apollo Systems During 2025
GlobeNewswire News Room· 2024-09-23 20:00
On demand manufacturer serves the world’s largest global brands, retailers and e-commerce platformsOperates three locations, nearshore and onshore, running 24/7, promoting new product delivery and replenishments anywhere in the US within 1-3 days after receiving an orderSignificant investment in Kornit Apollo fleet is a continued step in company’s digital transformation, shifting millions of bulk production impressions from screen to digital ROSH-HA`AYIN, Israel, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Kornit Di ...
Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza
GlobeNewswire News Room· 2024-09-23 20:00
SAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced the first subjects dosed in the Phase 2b NAVIGATE trial to evaluate the efficacy and safety of CD388 for the pre-exposure prophylaxis of influenza during the current flu season. The Phase 2b clini ...
22nd Century Announces New Branded Products Order with Customer for Southeast Asia
Newsfile· 2024-09-23 20:00
22nd Century Announces New Branded Products Order with Customer for Southeast AsiaNew Customer for 22nd Century's Internally Owned Moonlight Brand Could Increase Factory Volumes by More Than 30% When Fully Scaled, Improve Gross Profit ProfileSeptember 23, 2024 8:00 AM EDT | Source: 22nd Century GroupMocksville, North Carolina--(Newsfile Corp. - September 23, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smoke ...
AAR awarded five-year contract to perform airframe maintenance for U.S. Navy's P-8A Poseidon fleet
Prnewswire· 2024-09-23 20:00
WOOD DALE, Ill., Sept. 23, 2024 /PRNewswire/ -- AAR CORP. (NYSE: AIR), a leading provider of aviation services to commercial and government operators, MROs, and OEMs, has been awarded a five-year indefinite delivery / indefinite quantity contract with an aggregate ceiling value of approximately $1.2 billion by the U.S. Navy's Naval Air Systems Command (NAVAIR) to perform P-8A Poseidon depot airframe maintenance and depot field team support for the U.S. Navy, government of Australia, and foreign military sal ...
Envestnet Wins Five 2024 'Wealthies' Awards, Including Advisor Choice Award & Best Unified (All-in-One) System
Prnewswire· 2024-09-23 20:00
BERWYN, Pa., Sept. 23, 2024 /PRNewswire/ -- Envestnet (NYSE: ENV), a leading provider of integrated technology, data intelligence, and wealth solutions, has been recognized as an industry leader at the 2024 WealthManagement.com Industry Awards (the "Wealthies"). Including its Exchanges and partner integrations, Envestnet's ecosystem won five awards, including top honors for Advisor Choice and Best Unified (All-in-One) System.Now in its 10th year, the WealthManagement.com Industry Awards aims to honor outsta ...
Innovative Eyewear, Inc. Announces Exercise of Warrants for $2.6 Million Gross Proceeds
Prnewswire· 2024-09-23 20:00
MIAMI, Sept. 23, 2024 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (Nasdaq: LUCY), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase an aggregate of 263,160 shares of the Company's common stock originally issued by the Company on May 29, 2024, each having an original exercise price of $9.50 per share, at an e ...
MINISO to Acquire Stake in Yonghui Superstores, a Leading Chinese Retailer
Prnewswire· 2024-09-23 20:00
GUANGZHOU, China, Sept. 23, 2024 /PRNewswire/ -- MINISO Group Holding Limited (NYSE: MNSO; HKEX: 9896) ("MINISO", "MINISO Group" or the "Company"), a global value retailer offering a variety of trendy lifestyle products featuring IP design, today announced that it has entered into share purchase agreements with certain shareholders of Yonghui Superstores Co., Ltd ("Yonghui"), to acquire an aggregate of 29.4% of the issued and outstanding shares of Yonghui for a total cash consideration of approximately RMB6 ...
Moleculin Announces Positive In Vivo Efficacy Data of Annamycin in Orthotopic and Experimental Lung Metastatic Models of Sarcoma
Prnewswire· 2024-09-23 20:00
Data recently presented at the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung CancerTreatment with Annamycin results in statistically significant inhibition of tumor growth and extension of survival in orthotopic lung cancer modelsAnnamycin continues to be 100% non-cardiotoxicHOUSTON, Sept. 23, 2024 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candid ...